Interviews

IO Learning spoke with T.J. Bowen, PhD, Chief Scientific Officer and Co-Founder of Deep Lens, an artificial-intelligence technology company that offers patient-identification solutions to accelerate oncology clinical trial enrollment by...

The ICE3 trial was designed to evaluate the safety and efficacy of breast cryoablation in women older than 60 years with low-risk early-stage breast cancers. Dr Kenneth Tomkovich, co-principal investigator of ICE3, joined us to discuss the...

Barbara Hamilton, MD, joins us to discuss her recent book, "Save Lives, Enjoy Your Own," which encourages women to thrive in surgically oriented and traditionally male-dominated fields.

TARGET is a global real-world study set across eight countries that confirms TheraSphere as safe and effective treatment for HCC, demonstrating reproducible clinical outcomes across a broad patient population. Professor Marnix Lam and Dr....

Primary malignant liver tumors are rare in children, accounting for 1%-2% of all pediatric cancers. When chemotherapy fails, Y-90 TARE may offer an alternative therapy as a bridge to surgical resection or liver transplant or for palliation....

The Siemens Nexaris Angio-CT combines angiography with computed tomography systems in one environment for interventional procedures. IO Learning spoke with David Lacey, MD, an Interventional Radiologist at Iowa Methodist Medical Center. Dr...